Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day
Shares in Dr Reddy's Laboratories
Margins are also expected to see significant erosion, several dealers add.
Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at Rs 26.03 compared with mean estimate of Rs 27.89.
Dr Reddys Labs stock price
On September 19, 2014, Dr Reddys Laboratories closed at Rs 3218.40, up Rs 30.65, or 0.96 percent. The 52-week high of the share was Rs 3240.00 and the 52-week low was Rs 2250.00.
The company's trailing 12-month (TTM) EPS was at Rs 145.02 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 22.19. The latest book value of the company is Rs 547.59 per share. At current value, the price-to-book value of the company is 5.88.
Set email alert for
ADS BY GOOGLE
video of the day
Retail buyers, MFs are back; midcaps hold promise: Ambit